Answers are grounded in this paper and cite their sources.
The recent discovery of reversible chemical modifications on mRNA has opened a new era of post-transcriptional gene regulation in eukaryotes. Among the 15 types of modifications identified in mRNA of eukaryotes, N 7-methylguanosine (m 7 G) is unique owing to its presence in the 5′ cap structure. It remains unknown whether m 7 G is also present internally in mRNA, and this is largely attributed to the lack of an appropriate analytical method to differentiate internal m 7 G in mRNA from that in the 5′ cap. To address this analytical challenge, we developed a novel strategy of combining differential enzymatic digestion with liquid chromatography–tandem mass spectrometry analysis to quantify the levels of these two types of m 7 G modifications in mRNA. In particular, we found that S1 nuclease and phosphodiesterase I exhibit differential activities toward internal and 5′-terminal m 7 G. By using this method, we found that internal m 7 G was present in mRNA of cultured human cells as well as plants and rat tissue. In addition, our results showed that plants contain higher levels of internal m 7 G in mRNA than mammals. We also observed that exposure of rice to cadmium (Cd) stimulated marked diminution in the levels of m 7 G at both the 5′ cap and internal positions of mRNA, which was correlated with the Cd-induced elevated expression of m 7 G-decapping enzymes. Taken together, we reported here a strategy to distinguish internal and 5′-terminal m 7 G in mRNA, and by using this method, we demonstrated the prevalence of internal m 7 G modification in mRNA, which we believe will stimulate future functional studies of m 7 G on post-transcriptional gene regulation in eukaryotes.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: